Jacques Bosq
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers.
Journal: Science (New York, N.Y.)
Published: June 08, 2023
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study.
Journal: Haematologica
Published: October 27, 2021
Cancer Induces a Stress Ileopathy Depending on β-Adrenergic Receptors and Promoting Dysbiosis that Contributes to Carcinogenesis.
Journal: Cancer discovery
Published: July 25, 2021
Clinical significance of the loss of CD20 antigen on tumor cells in patients with relapsed or refractory follicular lymphoma.
Journal: Cancer drug resistance (Alhambra, Calif.)
Published: November 29, 2020
Expression of the Immune Checkpoint Regulators LAG-3 and TIM-3 in Classical Hodgkin Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 28, 2020
Screening a Broad Range of Solid and Haematological Tumour Types for CD70 Expression Using a Uniform IHC Methodology as Potential Patient Stratification Method.
Journal: Cancers
Published: September 20, 2019
Establishment and Characterization of a Reliable Xenograft Model of Hodgkin Lymphoma Suitable for the Study of Tumor Origin and the Design of New Therapies.
Journal: Cancers
Published: July 05, 2018
Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.
Journal: Cancers
Published: February 20, 2018
Daily Biopsy Diagnosis in Surgical Pathology: Concordance Between Light Microscopy and Whole-Slide Imaging in Real-Life Conditions.
Journal: American journal of clinical pathology
Published: February 17, 2018
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers.
Journal: PloS one
Published: July 23, 2017
Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors.
Journal: International journal of oncology
Published: August 08, 2016
Last Updated: 09/26/2026